Beach Investment Counsel’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Beach Investment Counsel’s Portfolio NBSE Stock Details NBSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-111	Closed	-$66K	–	167
2016 Q4	$66K	Buy	111 +3	+3%	+$3.17K	0.01%	162
2016 Q3	$123K	Sell	108 -1	-0.9%	-$1.08K	0.01%	163
2016 Q2	$119K	Sell	109 -21	-16%	-$26.4K	0.01%	155
2016 Q1	$167K	Hold	130	–	–	0.02%	164
2015 Q4	$318K	Hold	130	–	–	0.04%	146
2015 Q3	$143K	Buy	130 +66	+103%	+$76.4K	0.02%	162
2015 Q2	$64K	Hold	64	–	–	0.01%	180
2015 Q1	$65K	Sell	64 -24	-27%	-$79.2K	0.01%	173
2014 Q4	$293K	Buy	+88	New	+$270K	0.02%	161

Other funds holding NBSE

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bailard Foster City, California $4.91B AUM 31.75% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

GBA

Garrison Bradford & Associates New York $92.2M AUM 19.08% 1-Year Est. Return

Beach Investment Counsel's NBSE Position: Q1 2017 in Review

Beach Investment Counsel sold out of NeuBase Therapeutics, Inc. Common Stock (NBSE) in Q1 2017, closing a stake of 111 shares — an estimated $66K sold.

Beach Investment Counsel first reported a position in NBSE in Q4 2014 and held it in 9 quarters. The position peaked at $318K in Q4 2015. 40 funds tracked by Wall St. Rank hold NBSE as of Q1 2017.

Beach Investment Counsel reported no remaining NeuBase Therapeutics, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
Beach Investment Counsel sold 111 NeuBase Therapeutics, Inc. Common Stock shares in Q1 2017, an estimated $66K.
Beach Investment Counsel first reported a position in NeuBase Therapeutics, Inc. Common Stock in Q4 2014 and held it in 9 quarters.
Beach Investment Counsel's NeuBase Therapeutics, Inc. Common Stock position peaked at $318K in Q4 2015.
40 funds tracked by Wall St. Rank held NeuBase Therapeutics, Inc. Common Stock as of Q1 2017.

Based on Beach Investment Counsel's 13F filing for Q1 2017, filed 5 May 2017.